Tectonic Therapeutic, Inc.
TECX
Last
$23.33
Day
+2.5%
1y
+33.2%
5y
-64.0%
52w
-42.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0525d
EMA 21
24.98
EMA 50
27.81
EMA 200
27.94
20d high
-26.0%
5y high
-71.4%
5y range
22th
Positions held
Your positionsTECX isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-6
Hold
avoid
Signal
Sell
Target
$25.33
Stop
$20.60
Stop distance
11.7%
Target vs last
+8.6%
Fundamentals
| Market cap | $444.75M | Enterprise value | $222.08M | Trailing P/E | — | Forward P/E | -4.86 |
| PEG | — | Price / book | 1.95 | Beta | 0.38 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -33.8% | ROA | -22.3% | Debt / equity | 0.02 |
| Current ratio | 22.29 | Free cash flow | -$46.72M | Analyst recommendation | strong_buy | Mean target | $76.63 |
| 52w high | $39.53 | 52w low | $15.45 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$22.3M | -$25.2M | -$19.2M | -$19.0M | -$20.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$24.2M | -$27.3M | -$21.5M | -$21.9M | -$22.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$74.2M | -$58.0M | -$42.8M | -$32.2M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$84.0M | -$58.0M | -$44.6M | -$32.8M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-29 · Tectonic Therapeutic Says TX2100 Phase 1a Trial Met Primary Objectives
2026-09-10 · Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare
2026-09-03 · Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
2026-08-06 · Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
Price (daily)
Full chart · RSI · MACD · patternsTECX · daily-14.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin